Anti-LRIT2 antibodies are used in the immunodetection of the protein leucine rich repeat, Ig-like and transmembrane domains 2. In humans, the canonical protein has a reported length of 550 amino acid residues and a mass of 60.2 kDa. Its subcellular localization is in the membrane. Up to 2 different isoforms have been reported for this protein. It is notably expressed in the retina. Post-translational modifications have been described, including glycosylation. Synonyms for this target antigen include leucine rich repeat containing 22, leucine-rich repeat, immunoglobulin-like and transmembrane domains 2, leucine-rich repeat-containing protein 22, and leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 2. LRIT2 gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish, chimpanzee and chicken species. Immunocytochemistry is the most common application for the LRIT2 antibodies listed below. Immunofluorescence and Immunohistochemistry are also common applications.